CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Matthew Baker, Colin Walsh |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 6.30p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 10.20 |
52 Week Low | 2.90 |
Volume | 215,290 |
Shares Issued | 113.66m |
Market Cap | £7.16m |
Beta | 0.01 |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:28 | 8 @ 6.40p |
16:21 | 9 @ 6.40p |
16:11 | 5,000 @ 6.20p |
16:08 | 8 @ 6.40p |
15:51 | 4,500 @ 6.37p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research